Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare
  • Avantor and NIBRT have formed a new partnership to supply advanced Masterflex® equipment, essential products, and expert training to foster innovations in biopharma manufacturing

RADNOR, Pa., Oct. 23, 2024  /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced an expanded partnership with the National Institute for Bioprocessing Research and Training (NIBRT). The new collaboration will focus on addressing urgent bottlenecks in biopharma manufacturing, particularly in downstream optimization for monoclonal antibodies (mAbs), by providing cutting-edge equipment and specialized training.

Avantor will provide a full suite of leading aseptic fluid handling equipment, including Masterflex® pump systems and supporting single-use systems. These advanced tools are designed to create realistic biopharmaceutical workflows in NIBRT’s state-of-the-art training rooms, offering trainees the opportunity to gain hands-on experience with equipment that mirrors real-world industry settings.

“Monoclonal antibodies have revolutionized medicine by providing personalized treatments for chronic and debilitating conditions, but as researchers continue to advance their potential, manufacturers face increasing pressure to get new therapies to market quickly and safely,” said Benoit Gourdier, Executive Vice President and Head of Avantor’s Bioscience Production Segment. “The ability to handle large-scale fluid volumes, while maintaining quality in a closed system, is a key area that can be optimized to avoid delays and product loss. By combining our expertise with the latest technology, we are equipping industry partners with the tools and knowledge they need to maximize productivity and streamline their processes.”

In addition, Avantor’s team of bioprocessing experts are developing and delivering targeted training sessions to tackle pressing scale-up challenges. These expert-led trainings will focus on optimizing downstream processes for mAbs production, utilizing the full capabilities of the donated Masterflex® aseptic fluid transfer systems to enhance efficiency and scalability.

“At NIBRT, we are committed to providing world-class training and expertise to support the biopharma sector in overcoming key manufacturing challenges,” said Kate Cotter, Director of training delivery at NIBRT. “This enhanced partnership with Avantor allows us to further equip the industry with the tools and knowledge necessary to drive innovation and improve efficiency in critical areas, such as downstream processing for monoclonal antibodies. By combining advanced equipment with our specialized training programs, we enable our trainees to meet current and future skills demands with confidence.”

The partnership between Avantor and NIBRT represents a shared commitment to advancing the biopharmaceutical industry through cutting-edge research, training, and innovation. By equipping NIBRT with the latest technology and expertise, Avantor is helping to shape the future of bioprocessing and enabling the development of new and improved therapies.

About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedInX (Twitter) and Facebook.

About NIBRT
The National Institute for Bioprocessing Research and Training (NIBRT) is a global centre of excellence for training and research in biopharmaceutical manufacturing. NIBRT is located in a world class facility in Dublin, Ireland. This facility is purpose built to closely replicate a modern bioprocessing plant with state-of-the-art equipment and enables NIBRT to offer the highest quality training and research solutions. NIBRT’s mission is to support the growth and development of all aspects of the biopharmaceutical manufacturing industry. For more information, please visit www.nibrt.ie.

Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.Vanzanten@avantorsciences.com

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com

 

View original content:https://www.prnewswire.com/news-releases/avantor-strengthens-partnership-with-national-institute-for-bioprocessing-research-and-training-nibrt-to-address-critical-biopharma-industry-challenges-302283788.html

SOURCE Avantor and Financial News

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

2 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

2 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

5 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

5 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

5 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

5 hours ago